Collectively, these data suggest that ONC‐212 induces a pro‐apoptotic shift in the balance of the MCL1, BCL2 and BCLxL proteins in CLL cells and demonstrate that these effects are independent of TP53 status. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.